FN Q1 2026 Earnings Slight EPS Beat Amid Stable Performance OPRA Q1 2026 Earnings EPS Surpasses Estimates Stock Declines Modestly BMRA Q1 2026 Earnings Biomerica Reports Net Loss of 044 Per Share Amid Ongoing Development Efforts KBR Q1 2026 Earnings EPS Beat Fails to Lift Shares SRJN Q1 2026 Earnings EPS Beat Driven by Solid Operational Execution Actinium Pharmaceuticals ATNM Q1 2026 Earnings NarrowerThanExpected Loss as Pipeline Advances Continue